Complications After Major Surgery for Duodenopancreatic Neuroendocrine Tumors in Patients with MEN1: Results from a Nationwide Cohort

[1]  S. Sadowski,et al.  Pancreatic insufficiency following pancreatectomy: Does underlying tumor syndrome confer a greater risk? , 2020, American journal of surgery.

[2]  I. B. Borel Rinkes,et al.  Surgery for multiple endocrine neoplasia type 1‐related insulinoma: long‐term outcomes in a large international cohort , 2020, The British journal of surgery.

[3]  Jeffrey E. Lee,et al.  The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors , 2020, Pancreas.

[4]  I. B. Borel Rinkes,et al.  Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG) , 2019, Journal of surgical oncology.

[5]  U. Boggi,et al.  Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons. , 2019, Annals of surgery.

[6]  Henry W. Long,et al.  Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors , 2019, Nature Medicine.

[7]  P. Chanson,et al.  Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1 , 2018, Annals of surgery.

[8]  D. Raptis,et al.  Systematic review and meta-analysis of postoperative pancreatic fistula rates using the updated 2016 International Study Group Pancreatic Fistula definition in patients undergoing pancreatic resection with soft and hard pancreatic texture. , 2018, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[9]  J. Barkun,et al.  Toward a Consensus on Centralization in Surgery , 2018, Annals of surgery.

[10]  R. Jensen,et al.  Unmet Needs in Functional and Nonfunctional Pancreatic Neuroendocrine Neoplasms , 2018, Neuroendocrinology.

[11]  G. Valk,et al.  ‘Quality in, quality out’, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1 , 2018, Endocrine connections.

[12]  I. B. Borel Rinkes,et al.  DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment. , 2018, European journal of endocrinology.

[13]  I. B. Borel Rinkes,et al.  Expression of p27Kip1 and p18Ink4c in human multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors , 2018, Journal of Endocrinological Investigation.

[14]  I. B. Borel Rinkes,et al.  Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1—Results From the Dutch MEN1 Study Group , 2017, The Journal of clinical endocrinology and metabolism.

[15]  O. Dekkers,et al.  Prognostic value of WHO grade in pancreatic neuro-endocrine tumors in Multiple Endocrine Neoplasia type 1: Results from the DutchMEN1 Study Group. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[16]  G. Gronchi,et al.  Natural History of MEN1 GEP-NET: Single-Center Experience After a Long Follow-Up , 2017, World Journal of Surgery.

[17]  E. Baudin,et al.  Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study , 2017, Annals of surgery.

[18]  I. B. Borel Rinkes,et al.  Management of MEN1 Related Nonfunctioning Pancreatic NETs: A Shifting Paradigm Results From the DutchMEN1 Study Group , 2017, Annals of surgery.

[19]  M. Brandi,et al.  Operation for insulinomas in multiple endocrine neoplasia type 1: When pancreatoduodenectomy is appropriate , 2017, Surgery.

[20]  D. Gouma,et al.  The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After , 2017, Surgery.

[21]  G. Thompson,et al.  Long‐term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours , 2017, Clinical endocrinology.

[22]  D. Gouma,et al.  Definition and classification of chyle leak after pancreatic operation: A consensus statement by the International Study Group on Pancreatic Surgery , 2017, Surgery.

[23]  O. Dekkers,et al.  MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients , 2016, BMC Medicine.

[24]  R. Jensen,et al.  ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors , 2016, Neuroendocrinology.

[25]  R. Thakker,et al.  Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1. , 2015, The lancet. Diabetes & endocrinology.

[26]  P. Herscovitch,et al.  Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1. , 2015, Journal of the American College of Surgeons.

[27]  M. Carty,et al.  The influence of volume and experience on individual surgical performance: a systematic review. , 2015, Annals of surgery.

[28]  P. Chanson,et al.  Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d'étude des Tumeurs Endocrines (GTE) retrospective study. , 2015, European journal of endocrinology.

[29]  G. Valk,et al.  Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis. , 2014, Endocrine-related cancer.

[30]  V. Fendrich,et al.  Enucleation and Limited Pancreatic Resection Provide Long-Term Cure for Insulinoma in Multiple Endocrine Neoplasia Type 1 , 2013, Neuroendocrinology.

[31]  J. Barkun,et al.  The Comprehensive Complication Index: A Novel Continuous Scale to Measure Surgical Morbidity , 2013, Annals of surgery.

[32]  R. Jensen,et al.  Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1: A Prospective Study , 2013, Medicine.

[33]  M. Falconi,et al.  Partial Pancreaticoduodenectomy Can Provide Cure for Duodenal Gastrinoma Associated With Multiple Endocrine Neoplasia Type 1 , 2013, Annals of surgery.

[34]  J. Bilezikian,et al.  Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.

[35]  D. Gouma,et al.  Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality , 2012, The British journal of surgery.

[36]  Jeffrey E. Lee,et al.  Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important. , 2011, Surgery.

[37]  V. Fendrich,et al.  Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1 , 2011, Langenbeck's Archives of Surgery.

[38]  M. Koch,et al.  Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. , 2011, Surgery.

[39]  A. Scarpa,et al.  Presentation and Outcome of Pancreaticoduodenal Endocrine Tumors in Multiple Endocrine Neoplasia Type 1 Syndrome , 2011, Neuroendocrinology.

[40]  A. Tabarin,et al.  Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 Patients , 2010, World Journal of Surgery.

[41]  D. Farley,et al.  Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: Operative outcomes, long-term function, and quality of life. , 2007, Surgery.

[42]  D. Gouma,et al.  Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). , 2007, Surgery.

[43]  Abe Fingerhut,et al.  Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. , 2007, Surgery.

[44]  M. Brandi,et al.  Pancreatectomy in Multiple Endocrine Neoplasia Type 1-Related Gastrinomas and Pancreatic Endocrine Neoplasias , 2006, Annals of surgery.

[45]  J. Chayvialle,et al.  Epidemiology Data on 108 MEN 1 Patients From the GTE With Isolated Nonfunctioning Tumors of the Pancreas , 2006, Annals of surgery.

[46]  M. Rothmund,et al.  Outcome of Duodenopancreatic Resections in Patients With Multiple Endocrine Neoplasia Type 1 , 2005, Annals of surgery.

[47]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[48]  R. Jensen,et al.  Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form. , 2001, The Journal of clinical endocrinology and metabolism.

[49]  J. Norton,et al.  Comparison of Surgical Results in Patients With Advanced and Limited Disease With Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison Syndrome , 2001, Annals of surgery.

[50]  J. Norton,et al.  Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. , 2000, Annals of surgery.

[51]  P. Ruszniewski,et al.  Prognostic Factors in Patients With Zollinger-Ellison Syndrome and Multiple Endocrine Neoplasia Type 1 , 1999 .

[52]  A. Isidori,et al.  Lanreotide therapy vs active surveillance in MEN1-related pancreatic neuroendocrine tumors <2 cm. , 2019, The Journal of clinical endocrinology and metabolism.

[53]  G. Valk,et al.  'Quality in, quality out', a stepwise approach to EBM for rare diseases promoted by MEN1. , 2018, Endocrine connections.

[54]  M. Büchler,et al.  Use and results of consensus definitions in pancreatic surgery: a systematic review. , 2014, Surgery.

[55]  T. Kent,et al.  A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. , 2013, Journal of the American College of Surgeons.